The roles of intrinsically disordered proteins in neurodegeneration
Neurodegenerative diseases such as Amyotrophic Lateral Sclerosis, Alzheimer's disease, Parkinson's disease, and Huntington's disease share a common pathological hallmark: the accumulation of misfolded proteins, particularly involving intrinsically disordered proteins (IDPs) like TDP-4...
Saved in:
| Published in | Biochimica et biophysica acta. General subjects Vol. 1869; no. 4; p. 130772 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier B.V
01.04.2025
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0304-4165 1872-8006 1872-8006 |
| DOI | 10.1016/j.bbagen.2025.130772 |
Cover
Loading…
| Abstract | Neurodegenerative diseases such as Amyotrophic Lateral Sclerosis, Alzheimer's disease, Parkinson's disease, and Huntington's disease share a common pathological hallmark: the accumulation of misfolded proteins, particularly involving intrinsically disordered proteins (IDPs) like TDP-43, FUS, Tau, α-synuclein, and Huntingtin. These proteins undergo pathological aggregation, forming toxic inclusions that disrupt cellular function. The dysregulation of proteostasis mechanisms, including the ubiquitin-proteasome system (UPS), ubiquitin-independent proteasome system (UIPS), autophagy, and molecular chaperones, exacerbates these proteinopathies by failing to clear misfolded proteins effectively. Emerging therapeutic strategies aim to restore proteostasis through proteasome activators, autophagy enhancers, and chaperone-based interventions to prevent the toxic accumulation of IDPs. Additionally, understanding liquid-liquid phase separation (LLPS) and its role in stress granule dynamics offers novel insights into how aberrant phase transitions contribute to neurodegeneration. By targeting the molecular pathways involved in IDP aggregation and proteostasis regulation, and better understanding the specificity of each component, research in this area will pave the way for innovative therapeutic approaches to combat these neurodegenerative diseases. This review discusses the molecular mechanisms underpinning IDP pathology, highlights recent advancements in drug discovery, and explores the potential of targeting proteostasis machinery to develop effective therapies.
•IDP misfolding and aggregation in ALS, AD, PD, and HD form toxic inclusions that disrupt cell function.•LLPS forms stress granules; aberrant phase separation by IDPs may drive neurodegeneration.•Chaperones (e.g., Hsps) assist protein folding and prevent abnormal IDP phase transitions.•New therapeutic strategies target IDP hotspots or protein modifiers, offering options beyond traditional drug design. |
|---|---|
| AbstractList | Neurodegenerative diseases such as Amyotrophic Lateral Sclerosis, Alzheimer's disease, Parkinson's disease, and Huntington's disease share a common pathological hallmark: the accumulation of misfolded proteins, particularly involving intrinsically disordered proteins (IDPs) like TDP-43, FUS, Tau, α-synuclein, and Huntingtin. These proteins undergo pathological aggregation, forming toxic inclusions that disrupt cellular function. The dysregulation of proteostasis mechanisms, including the ubiquitin-proteasome system (UPS), ubiquitin-independent proteasome system (UIPS), autophagy, and molecular chaperones, exacerbates these proteinopathies by failing to clear misfolded proteins effectively. Emerging therapeutic strategies aim to restore proteostasis through proteasome activators, autophagy enhancers, and chaperone-based interventions to prevent the toxic accumulation of IDPs. Additionally, understanding liquid-liquid phase separation (LLPS) and its role in stress granule dynamics offers novel insights into how aberrant phase transitions contribute to neurodegeneration. By targeting the molecular pathways involved in IDP aggregation and proteostasis regulation, and better understanding the specificity of each component, research in this area will pave the way for innovative therapeutic approaches to combat these neurodegenerative diseases. This review discusses the molecular mechanisms underpinning IDP pathology, highlights recent advancements in drug discovery, and explores the potential of targeting proteostasis machinery to develop effective therapies.
•IDP misfolding and aggregation in ALS, AD, PD, and HD form toxic inclusions that disrupt cell function.•LLPS forms stress granules; aberrant phase separation by IDPs may drive neurodegeneration.•Chaperones (e.g., Hsps) assist protein folding and prevent abnormal IDP phase transitions.•New therapeutic strategies target IDP hotspots or protein modifiers, offering options beyond traditional drug design. Neurodegenerative diseases such as Amyotrophic Lateral Sclerosis, Alzheimer's disease, Parkinson's disease, and Huntington's disease share a common pathological hallmark: the accumulation of misfolded proteins, particularly involving intrinsically disordered proteins (IDPs) like TDP-43, FUS, Tau, α-synuclein, and Huntingtin. These proteins undergo pathological aggregation, forming toxic inclusions that disrupt cellular function. The dysregulation of proteostasis mechanisms, including the ubiquitin-proteasome system (UPS), ubiquitin-independent proteasome system (UIPS), autophagy, and molecular chaperones, exacerbates these proteinopathies by failing to clear misfolded proteins effectively. Emerging therapeutic strategies aim to restore proteostasis through proteasome activators, autophagy enhancers, and chaperone-based interventions to prevent the toxic accumulation of IDPs. Additionally, understanding liquid-liquid phase separation (LLPS) and its role in stress granule dynamics offers novel insights into how aberrant phase transitions contribute to neurodegeneration. By targeting the molecular pathways involved in IDP aggregation and proteostasis regulation, and better understanding the specificity of each component, research in this area will pave the way for innovative therapeutic approaches to combat these neurodegenerative diseases. This review discusses the molecular mechanisms underpinning IDP pathology, highlights recent advancements in drug discovery, and explores the potential of targeting proteostasis machinery to develop effective therapies. Neurodegenerative diseases such as Amyotrophic Lateral Sclerosis, Alzheimer's disease, Parkinson's disease, and Huntington's disease share a common pathological hallmark: the accumulation of misfolded proteins, particularly involving intrinsically disordered proteins (IDPs) like TDP-43, FUS, Tau, α-synuclein, and Huntingtin. These proteins undergo pathological aggregation, forming toxic inclusions that disrupt cellular function. The dysregulation of proteostasis mechanisms, including the ubiquitin-proteasome system (UPS), ubiquitin-independent proteasome system (UIPS), autophagy, and molecular chaperones, exacerbates these proteinopathies by failing to clear misfolded proteins effectively. Emerging therapeutic strategies aim to restore proteostasis through proteasome activators, autophagy enhancers, and chaperone-based interventions to prevent the toxic accumulation of IDPs. Additionally, understanding liquid-liquid phase separation (LLPS) and its role in stress granule dynamics offers novel insights into how aberrant phase transitions contribute to neurodegeneration. By targeting the molecular pathways involved in IDP aggregation and proteostasis regulation, and better understanding the specificity of each component, research in this area will pave the way for innovative therapeutic approaches to combat these neurodegenerative diseases. This review discusses the molecular mechanisms underpinning IDP pathology, highlights recent advancements in drug discovery, and explores the potential of targeting proteostasis machinery to develop effective therapies.Neurodegenerative diseases such as Amyotrophic Lateral Sclerosis, Alzheimer's disease, Parkinson's disease, and Huntington's disease share a common pathological hallmark: the accumulation of misfolded proteins, particularly involving intrinsically disordered proteins (IDPs) like TDP-43, FUS, Tau, α-synuclein, and Huntingtin. These proteins undergo pathological aggregation, forming toxic inclusions that disrupt cellular function. The dysregulation of proteostasis mechanisms, including the ubiquitin-proteasome system (UPS), ubiquitin-independent proteasome system (UIPS), autophagy, and molecular chaperones, exacerbates these proteinopathies by failing to clear misfolded proteins effectively. Emerging therapeutic strategies aim to restore proteostasis through proteasome activators, autophagy enhancers, and chaperone-based interventions to prevent the toxic accumulation of IDPs. Additionally, understanding liquid-liquid phase separation (LLPS) and its role in stress granule dynamics offers novel insights into how aberrant phase transitions contribute to neurodegeneration. By targeting the molecular pathways involved in IDP aggregation and proteostasis regulation, and better understanding the specificity of each component, research in this area will pave the way for innovative therapeutic approaches to combat these neurodegenerative diseases. This review discusses the molecular mechanisms underpinning IDP pathology, highlights recent advancements in drug discovery, and explores the potential of targeting proteostasis machinery to develop effective therapies. |
| ArticleNumber | 130772 |
| Author | Morimoto, Satoru Utami, Kagistia Hana Mitsukura, Yasue Okano, Hideyuki |
| Author_xml | – sequence: 1 givenname: Kagistia Hana surname: Utami fullname: Utami, Kagistia Hana organization: Keio University Regenerative Medicine Research Center, Kanagawa 210-0821, Japan – sequence: 2 givenname: Satoru surname: Morimoto fullname: Morimoto, Satoru email: satoru_morimoto@keio.jp organization: Keio University Regenerative Medicine Research Center, Kanagawa 210-0821, Japan – sequence: 3 givenname: Yasue surname: Mitsukura fullname: Mitsukura, Yasue organization: Faculty of Science and Technology, Keio University, Kanagawa 223-0061, Japan – sequence: 4 givenname: Hideyuki surname: Okano fullname: Okano, Hideyuki organization: Keio University Regenerative Medicine Research Center, Kanagawa 210-0821, Japan |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39954969$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkU1PAyEURYmp0bb6D4yZpZupfMzA4MLENH4lJm7qmlB4ozRTqDA18d9LHXXhQtmw4JzHy70TNPLBA0InBM8IJvx8NVsu9TP4GcW0nhGGhaB7aEwaQcsGYz5CY8xwVVaE14doktIK51PL-gAdMinrSnI5RvPFCxQxdJCK0BbO99H55IzuuvfCuhSihQi22MTQQ37JROFhG4OF_DVE3bvgj9B-q7sEx1_3FD3dXC_md-XD4-39_OqhNFVF-pIJoKbmBERFcEu5bIxkljFCrNaWSymoJcYIijFogwnjTWssaytWN5K3lk3R2TA3b_O6hdSrtUsGuk57CNukWDYpz5r4HyVcsFpQ0WT09AvdLtdg1Sa6tY7v6jujDFQDYGJIKUL7gxCsdlWolRqqULsq1FBF1i5-acb1n3n1UbvuP_lykCHn-eYgqmQceAPWRTC9ssH9PeADl-mlSw |
| CitedBy_id | crossref_primary_10_3390_toxics13030178 |
| Cites_doi | 10.1073/pnas.85.15.5733 10.1016/j.stem.2022.01.007 10.3390/cells10020262 10.1016/j.ijbiomac.2023.126027 10.1146/annurev-biophys-121219-081629 10.1038/s44320-023-00005-6 10.1038/s41467-017-00480-0 10.1002/wcms.1685 10.3390/cells11152262 10.1007/s13311-013-0182-9 10.3389/fnmol.2019.00301 10.1093/nar/gkad928 10.1093/nar/gkae655 10.1016/j.sbi.2023.102678 10.1016/j.bpj.2022.09.031 10.1038/s41467-020-16580-3 10.31887/DCNS.2004.6.3/galexander 10.1002/mds.10140 10.1186/s12964-022-00821-7 10.1016/j.bbamcr.2020.118876 10.1021/cr500288y 10.1016/j.cell.2018.12.035 10.1038/s41582-022-00749-z 10.1242/jcs.038950 10.1074/jbc.M117.794602 10.1111/febs.17084 10.3389/fnmol.2023.1242925 10.1155/2012/731526 10.1007/s11011-021-00791-8 10.1016/j.cell.2018.03.025 10.1016/j.jalz.2012.01.011 10.1016/j.stem.2023.04.017 10.1128/jvi.69.6.3584-3596.1995 10.14336/AD.2023.1118 10.1016/j.bbadis.2015.12.002 10.1021/bi00191a006 10.1016/j.molcel.2018.07.002 10.3233/JAD-179928 10.3390/cells11111732 10.1056/NEJMra1205406 10.1016/j.jmb.2018.03.028 10.1038/s41591-018-0140-5 10.1074/jbc.R115.695056 10.1016/0022-510X(86)90167-X 10.1021/acs.chemrev.1c00774 10.1111/j.1582-4934.2009.00609.x 10.1016/0092-8674(93)90585-E 10.1073/pnas.83.11.4040 10.1038/s12276-020-00513-7 10.1016/j.tcb.2016.05.004 10.3389/fmolb.2022.826719 10.3934/Neuroscience.2021005 10.1074/jbc.M105196200 10.1007/s12551-022-00968-0 10.1186/s43556-022-00075-2 10.1038/s41580-022-00558-8 10.3389/fnagi.2015.00018 10.3389/fnagi.2014.00087 10.1016/j.jmb.2021.167208 10.1016/j.molcel.2022.08.016 10.1016/j.celrep.2014.03.019 10.1038/nrneurol.2011.153 10.1021/cr400713r 10.3390/cells11132063 10.1038/nrn3121 10.2174/092986708785909111 10.1021/jacs.7b06659 10.3390/ijms232214050 10.1039/D0SC04395H 10.15252/embj.201798049 10.1016/j.ejphar.2020.173554 10.1111/jnc.13625 10.1186/s40478-021-01288-2 10.1021/acs.jpcb.3c04052 10.3389/fnmol.2019.00309 10.1523/JNEUROSCI.16-14-04491.1996 10.1073/pnas.182276099 10.1056/NEJMoa2202867 10.1016/j.gde.2017.01.008 10.1016/S0896-6273(00)81108-3 10.1038/ncomms1255 10.1046/j.1471-4159.2003.02287.x 10.1038/s41582-023-00883-2 10.3390/ijms232214498 10.1097/00002093-198701030-00021 10.1186/s13024-019-0329-1 10.1093/bioinformatics/bti541 10.2741/3594 10.1016/j.jmb.2022.167714 10.1016/j.csbj.2021.06.042 10.7554/eLife.69377 10.1016/j.molcel.2015.08.018 10.1016/S0896-6273(03)00568-3 10.1038/nchembio.797 10.1016/j.bbapap.2019.07.013 |
| ContentType | Journal Article |
| Copyright | 2025 The Author(s) Copyright © 2025 The Author(s). Published by Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2025 The Author(s) – notice: Copyright © 2025 The Author(s). Published by Elsevier B.V. All rights reserved. |
| DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 |
| DOI | 10.1016/j.bbagen.2025.130772 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | MEDLINE AGRICOLA MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Chemistry Biology |
| EISSN | 1872-8006 |
| ExternalDocumentID | 39954969 10_1016_j_bbagen_2025_130772 S0304416525000170 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Review |
| GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 23N 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 6I. 7-5 71M 8P~ 9JM AACTN AAEDT AAEDW AAFTH AAHBH AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXKI AAXUO ABEFU ABFNM ABGSF ABMAC ABUDA ABWVN ABXDB ACDAQ ACIUM ACRLP ACRPL ADBBV ADEZE ADMUD ADNMO ADUVX AEBSH AEIPS AEKER AFJKZ AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC CS3 EBS EFJIC EJD EO8 EO9 EP2 EP3 FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HLW HVGLF HZ~ IHE J1W KOM LX3 M41 MO0 N9A O-L O9- OAUVE OHT OZT P-8 P-9 PC. Q38 R2- ROL RPZ SBG SCC SDF SDG SDP SES SEW SPCBC SSU SSZ T5K UQL WH7 WUQ XJT XPP ~G- AATTM AAYWO AAYXX ACVFH ADCNI AEHWI AEUPX AFPUW AGCQF AGQPQ AGRNS AIGII AIIUN AKBMS AKYEP APXCP BNPGV CITATION SSH CGR CUY CVF ECM EFKBS EIF NPM 7X8 7S9 L.6 |
| ID | FETCH-LOGICAL-c441t-37e2c561e7410f2698c93d3311daad69972d1cc7200eac01368fcd3f435896fd3 |
| IEDL.DBID | .~1 |
| ISSN | 0304-4165 1872-8006 |
| IngestDate | Fri Aug 22 20:25:28 EDT 2025 Tue Aug 05 09:31:14 EDT 2025 Mon Jul 21 05:56:25 EDT 2025 Tue Jul 01 05:18:17 EDT 2025 Thu Apr 24 23:00:34 EDT 2025 Sat Mar 08 15:49:50 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | Aggregation Proteostasis Neurodegenerative diseases Intrinsically disordered proteins Chaperone Liquid-liquid phase separation Autophagy |
| Language | English |
| License | This is an open access article under the CC BY license. Copyright © 2025 The Author(s). Published by Elsevier B.V. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c441t-37e2c561e7410f2698c93d3311daad69972d1cc7200eac01368fcd3f435896fd3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S0304416525000170 |
| PMID | 39954969 |
| PQID | 3167357278 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_3200263687 proquest_miscellaneous_3167357278 pubmed_primary_39954969 crossref_primary_10_1016_j_bbagen_2025_130772 crossref_citationtrail_10_1016_j_bbagen_2025_130772 elsevier_sciencedirect_doi_10_1016_j_bbagen_2025_130772 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | April 2025 2025-04-00 20250401 |
| PublicationDateYYYYMMDD | 2025-04-01 |
| PublicationDate_xml | – month: 04 year: 2025 text: April 2025 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Biochimica et biophysica acta. General subjects |
| PublicationTitleAlternate | Biochim Biophys Acta Gen Subj |
| PublicationYear | 2025 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Vazquez, Toledo, Gianotti, Ermácora (bb0150) 2022; 4 Pagano (bb0355) 2022; 387 Song (bb0430) 2024; 15 M., D., M., R., N.S., R., V., D.-U. & J., Z (bb0535) 2015; 469 Vidović, Rikalovic (bb0350) 2022; 11 Yuzwa (bb0520) 2012; 8 Chakraborty, Zweckstetter (bb0110) 2023; 82 Ambadipudi, Biernat, Riedel, Mandelkow, Zweckstetter (bb0270) 2017; 8 Jeon, Ham, Park, Lee (bb0140) 2022; 11 Delacourte, Defossez (bb0250) 1986; 76 Aspromonte (bb0100) 2024; 52 Sang (bb0310) 2022; 82 Byeon (bb0070) 2024; 291 Küffner (bb0155) 2021; 12 Protter, Parker (bb0505) 2016; 26 Zhang (bb0515) 2018; 173 Dosztányi, Csizmok, Tompa, Simon (bb0545) 2005; 21 Yu (bb0485) 2021; 371 Dauer, Przedborski (bb0180) 2003; 39 McGurk (bb0465) 2018; 71 Tsangaris (bb0085) 2023; 127 Trivedi, Nagarajaram (bb0005) 2022; 23 Orti, Navarro, Rabinovich, Wodak, Marino-Buslje (bb0145) 2021; 19 Ou, Wu, Harrich, García-Martínez, Gaynor (bb0440) 1995; 69 Magrinelli (bb0320) 2016; 2016 Zhou, Zhao, Dunker (bb0200) 2018; 430 Schulte, Littleton (bb0365) 2011; 5 Gong, Iqbal (bb0260) 2008; 15 Hardiman, Van Den Berg, Kiernan (bb0385) 2011; 7 Kolarova, García-Sierra, Bartos, Ricny, Ripova (bb0235) 2012 Li (bb0120) 2022; 3 Lee (bb0065) 2024; 20 Bharadwaj, Dubey, Masters, Martins, Macreadie (bb0225) 2009; 13 Alexander (bb0185) 2004; 6 Ochneva (bb0090) 2022; 23 Uversky (bb0015) 2014; 19 Choi, Ryter, Levine (bb0525) 2013; 368 Wegmann (bb0275) 2018; 37 Talafous, Marcinowski, Klopman, Zagorski (bb0230) 1994; 33 Sundgreen (bb0540) 2019; 20 Glineburg (bb0470) 2024; 52 Wood, Mirra, Pollock, Binder (bb0240) 1986; 83 Choi, Holehouse, Pappu (bb0130) 2020; 49 Braak, Del Tredici (bb0170) 2012; 8 Naskar, Nayak, Salaikumaran, Vishal, Gopal (bb0475) 2023; 16 Carlomagno (bb0295) 2017; 292 Reid Alderson, Pritišanac, Kolaric, Moses, Forman-Kay (bb0055) 2023; 120 Mitra (bb0045) 2019; 1867 Boczek (bb0480) 2021; 10 Uversky (bb0095) 2014; 114 Bergman, Deuschl (bb0315) 2002; 17 Wang, Xiong, Lai (bb0060) 2023; 13 Cohen (bb0285) 2011; 2 Birol, Melo (bb0370) 2020; 12 Chen, Ferrone, Wetzel (bb0375) 2002; 99 De Sancho (bb0125) 2022; 121 Haase, Stieler, Arendt, Holzer (bb0290) 2004; 88 MacDonald (bb0360) 1993; 72 Uversky (bb0025) 2014; 114 Warner (bb0380) 2017; 139 Gómez-Virgilio (bb0530) 2022; 11 (bb0175) 2020; 1 Hofmann, Kedersha, Anderson, Ivanov (bb0510) 2021; 1868 Abyzov, Blackledge, Zweckstetter (bb0105) 2022; 122 Mormino, Papp (bb0220) 2018; 64 Takahashi (bb0405) 2019; 59 Schiavina (bb0080) 2024; 18 Bah, Forman-Kay (bb0205) 2016; 291 Jo (bb0425) 2020; 52 Carey, Guo (bb0115) 2022; 9 Alberti, Gladfelter, Mittag (bb0160) 2019; 176 Bondos, Dunker, Uversky (bb0030) 2022; 20 Liu (bb0300) 2016; 1862 Ratti, Buratti (bb0450) 2016 Reiner (bb0195) 1988; 85 Tzioras, McGeachan, Durrant, Spires-Jones (bb0215) 2023; 19 Cleveland (bb0190) 1999; 24 Uversky (bb0020) 2015; 7 Uversky (bb0035) 2009; 14 Benazzouz, Mamad, Abedi, Bouali-Benazzouz, Chetrit (bb0325) 2014; 6 Kirby, Al Sultan, Waller, Heath (bb0390) 2016 Calabrò, Rinaldi, Santoro, Crisafulli (bb0210) 2021; 8 Wood, Mirra, Pollock, Binder (bb0245) 1987; 1 Vaz, Silvestre (bb0265) 2020; 887 Okano, Morimoto (bb0400) 2022; 29 Shorter (bb0490) 2007; 16 Congdon, Ji, Tetlow, Jiang, Sigurdsson (bb0255) 2023; 19 Gao, Briano, Komer, Burré (bb0330) 2023; 435 Morimoto (bb0415) 2023; 30 Neumann (bb0395) 2006; 314 Lee, Lee, Trojanowski (bb0445) 2012; 13 Coskuner-Weber, Mirzanli, Uversky (bb0010) 2022; 14 Fujimori (bb0410) 2018; 24 Djulbegovic, Taylor Gonzalez, Uversky, Shields, Karp (bb0075) 2023; 250 Gómez-Isla (bb0165) 1996; 16 Meade, Fairlie, Mason (bb0345) 2019; 14 Ayyadevara, Ganne, Balasubramaniam, Shmookler Reis (bb0040) 2022; 37 Marotta (bb0340) 2021; 9 Rippin, Eldar-Finkelman (bb0500) 2021; 10 François-Moutal (bb0455) 2019; 12 Wainger (bb0420) 2014; 7 Ayala (bb0435) 2008; 121 Lin, Protter, Rosen, Parker (bb0460) 2015; 60 Hirose, Ninomiya, Nakagawa, Yamazaki (bb0135) 2023; 24 Ruff, Pappu (bb0050) 2021; 433 Von Bergen (bb0280) 2001; 276 Kanaan, Hamel, Grabinski, Combs (bb0305) 2020; 11 Shorter (bb0495) 2017; 44 Nakamura (bb0335) 2013; 10 Carey (10.1016/j.bbagen.2025.130772_bb0115) 2022; 9 Braak (10.1016/j.bbagen.2025.130772_bb0170) 2012; 8 Lin (10.1016/j.bbagen.2025.130772_bb0460) 2015; 60 François-Moutal (10.1016/j.bbagen.2025.130772_bb0455) 2019; 12 Ruff (10.1016/j.bbagen.2025.130772_bb0050) 2021; 433 Cohen (10.1016/j.bbagen.2025.130772_bb0285) 2011; 2 Byeon (10.1016/j.bbagen.2025.130772_bb0070) 2024; 291 Protter (10.1016/j.bbagen.2025.130772_bb0505) 2016; 26 Wood (10.1016/j.bbagen.2025.130772_bb0245) 1987; 1 Magrinelli (10.1016/j.bbagen.2025.130772_bb0320) 2016; 2016 M., D., M., R., N.S., R., V., D.-U. & J., Z (10.1016/j.bbagen.2025.130772_bb0535) 2015; 469 Warner (10.1016/j.bbagen.2025.130772_bb0380) 2017; 139 Nakamura (10.1016/j.bbagen.2025.130772_bb0335) 2013; 10 Vazquez (10.1016/j.bbagen.2025.130772_bb0150) 2022; 4 Kolarova (10.1016/j.bbagen.2025.130772_bb0235) 2012 Vaz (10.1016/j.bbagen.2025.130772_bb0265) 2020; 887 Pagano (10.1016/j.bbagen.2025.130772_bb0355) 2022; 387 Wang (10.1016/j.bbagen.2025.130772_bb0060) 2023; 13 Mitra (10.1016/j.bbagen.2025.130772_bb0045) 2019; 1867 Bondos (10.1016/j.bbagen.2025.130772_bb0030) 2022; 20 De Sancho (10.1016/j.bbagen.2025.130772_bb0125) 2022; 121 Ayyadevara (10.1016/j.bbagen.2025.130772_bb0040) 2022; 37 Coskuner-Weber (10.1016/j.bbagen.2025.130772_bb0010) 2022; 14 Boczek (10.1016/j.bbagen.2025.130772_bb0480) 2021; 10 Chen (10.1016/j.bbagen.2025.130772_bb0375) 2002; 99 Choi (10.1016/j.bbagen.2025.130772_bb0130) 2020; 49 Neumann (10.1016/j.bbagen.2025.130772_bb0395) 2006; 314 Uversky (10.1016/j.bbagen.2025.130772_bb0020) 2015; 7 Cleveland (10.1016/j.bbagen.2025.130772_bb0190) 1999; 24 Zhou (10.1016/j.bbagen.2025.130772_bb0200) 2018; 430 Liu (10.1016/j.bbagen.2025.130772_bb0300) 2016; 1862 Abyzov (10.1016/j.bbagen.2025.130772_bb0105) 2022; 122 Uversky (10.1016/j.bbagen.2025.130772_bb0095) 2014; 114 Naskar (10.1016/j.bbagen.2025.130772_bb0475) 2023; 16 Haase (10.1016/j.bbagen.2025.130772_bb0290) 2004; 88 Yuzwa (10.1016/j.bbagen.2025.130772_bb0520) 2012; 8 Hirose (10.1016/j.bbagen.2025.130772_bb0135) 2023; 24 Lee (10.1016/j.bbagen.2025.130772_bb0065) 2024; 20 Ratti (10.1016/j.bbagen.2025.130772_bb0450) 2016 Djulbegovic (10.1016/j.bbagen.2025.130772_bb0075) 2023; 250 Zhang (10.1016/j.bbagen.2025.130772_bb0515) 2018; 173 Benazzouz (10.1016/j.bbagen.2025.130772_bb0325) 2014; 6 Kirby (10.1016/j.bbagen.2025.130772_bb0390) 2016 Reid Alderson (10.1016/j.bbagen.2025.130772_bb0055) 2023; 120 Von Bergen (10.1016/j.bbagen.2025.130772_bb0280) 2001; 276 Glineburg (10.1016/j.bbagen.2025.130772_bb0470) 2024; 52 Uversky (10.1016/j.bbagen.2025.130772_bb0025) 2014; 114 Mormino (10.1016/j.bbagen.2025.130772_bb0220) 2018; 64 (10.1016/j.bbagen.2025.130772_bb0175) 2020; 1 McGurk (10.1016/j.bbagen.2025.130772_bb0465) 2018; 71 Bharadwaj (10.1016/j.bbagen.2025.130772_bb0225) 2009; 13 Ou (10.1016/j.bbagen.2025.130772_bb0440) 1995; 69 Hofmann (10.1016/j.bbagen.2025.130772_bb0510) 2021; 1868 Wainger (10.1016/j.bbagen.2025.130772_bb0420) 2014; 7 Alexander (10.1016/j.bbagen.2025.130772_bb0185) 2004; 6 Song (10.1016/j.bbagen.2025.130772_bb0430) 2024; 15 Chakraborty (10.1016/j.bbagen.2025.130772_bb0110) 2023; 82 Yu (10.1016/j.bbagen.2025.130772_bb0485) 2021; 371 Li (10.1016/j.bbagen.2025.130772_bb0120) 2022; 3 Trivedi (10.1016/j.bbagen.2025.130772_bb0005) 2022; 23 Jeon (10.1016/j.bbagen.2025.130772_bb0140) 2022; 11 Tsangaris (10.1016/j.bbagen.2025.130772_bb0085) 2023; 127 Birol (10.1016/j.bbagen.2025.130772_bb0370) 2020; 12 Dauer (10.1016/j.bbagen.2025.130772_bb0180) 2003; 39 Meade (10.1016/j.bbagen.2025.130772_bb0345) 2019; 14 Dosztányi (10.1016/j.bbagen.2025.130772_bb0545) 2005; 21 Takahashi (10.1016/j.bbagen.2025.130772_bb0405) 2019; 59 Alberti (10.1016/j.bbagen.2025.130772_bb0160) 2019; 176 Delacourte (10.1016/j.bbagen.2025.130772_bb0250) 1986; 76 Morimoto (10.1016/j.bbagen.2025.130772_bb0415) 2023; 30 Uversky (10.1016/j.bbagen.2025.130772_bb0035) 2009; 14 Wegmann (10.1016/j.bbagen.2025.130772_bb0275) 2018; 37 Bergman (10.1016/j.bbagen.2025.130772_bb0315) 2002; 17 MacDonald (10.1016/j.bbagen.2025.130772_bb0360) 1993; 72 Calabrò (10.1016/j.bbagen.2025.130772_bb0210) 2021; 8 Gong (10.1016/j.bbagen.2025.130772_bb0260) 2008; 15 Uversky (10.1016/j.bbagen.2025.130772_bb0015) 2014; 19 Carlomagno (10.1016/j.bbagen.2025.130772_bb0295) 2017; 292 Shorter (10.1016/j.bbagen.2025.130772_bb0490) 2007; 16 Fujimori (10.1016/j.bbagen.2025.130772_bb0410) 2018; 24 Ayala (10.1016/j.bbagen.2025.130772_bb0435) 2008; 121 Sundgreen (10.1016/j.bbagen.2025.130772_bb0540) 2019; 20 Schulte (10.1016/j.bbagen.2025.130772_bb0365) 2011; 5 Gao (10.1016/j.bbagen.2025.130772_bb0330) 2023; 435 Reiner (10.1016/j.bbagen.2025.130772_bb0195) 1988; 85 Choi (10.1016/j.bbagen.2025.130772_bb0525) 2013; 368 Marotta (10.1016/j.bbagen.2025.130772_bb0340) 2021; 9 Shorter (10.1016/j.bbagen.2025.130772_bb0495) 2017; 44 Bah (10.1016/j.bbagen.2025.130772_bb0205) 2016; 291 Talafous (10.1016/j.bbagen.2025.130772_bb0230) 1994; 33 Wood (10.1016/j.bbagen.2025.130772_bb0240) 1986; 83 Sang (10.1016/j.bbagen.2025.130772_bb0310) 2022; 82 Orti (10.1016/j.bbagen.2025.130772_bb0145) 2021; 19 Ochneva (10.1016/j.bbagen.2025.130772_bb0090) 2022; 23 Rippin (10.1016/j.bbagen.2025.130772_bb0500) 2021; 10 Congdon (10.1016/j.bbagen.2025.130772_bb0255) 2023; 19 Kanaan (10.1016/j.bbagen.2025.130772_bb0305) 2020; 11 Gómez-Virgilio (10.1016/j.bbagen.2025.130772_bb0530) 2022; 11 Vidović (10.1016/j.bbagen.2025.130772_bb0350) 2022; 11 Tzioras (10.1016/j.bbagen.2025.130772_bb0215) 2023; 19 Okano (10.1016/j.bbagen.2025.130772_bb0400) 2022; 29 Lee (10.1016/j.bbagen.2025.130772_bb0445) 2012; 13 Aspromonte (10.1016/j.bbagen.2025.130772_bb0100) 2024; 52 Hardiman (10.1016/j.bbagen.2025.130772_bb0385) 2011; 7 Jo (10.1016/j.bbagen.2025.130772_bb0425) 2020; 52 Küffner (10.1016/j.bbagen.2025.130772_bb0155) 2021; 12 Schiavina (10.1016/j.bbagen.2025.130772_bb0080) 2024; 18 Gómez-Isla (10.1016/j.bbagen.2025.130772_bb0165) 1996; 16 Ambadipudi (10.1016/j.bbagen.2025.130772_bb0270) 2017; 8 |
| References_xml | – volume: 9 year: 2022 ident: bb0115 article-title: Liquid-liquid phase separation of TDP-43 and FUS in physiology and pathology of neurodegenerative diseases publication-title: Front. Mol. Biosci. – volume: 88 year: 2004 ident: bb0290 article-title: Pseudophosphorylation of tau protein alters its ability for self-aggregation publication-title: J. Neurochem. – volume: 16 year: 2007 ident: bb0490 article-title: Hsp104: a weapon to combat diverse neurodegenerative disorders publication-title: NeuroSignals – volume: 4 year: 2022 ident: bb0150 article-title: Protein conformation and biomolecular condensates publication-title: Curr. Res. Struct. Biol. – volume: 19 year: 2021 ident: bb0145 article-title: Insight into membraneless organelles and their associated proteins: drivers, clients and regulators publication-title: Comput. Struct. Biotechnol. J. – volume: 13 year: 2012 ident: bb0445 article-title: Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration publication-title: Nat. Rev. Neurosci. – volume: 52 year: 2020 ident: bb0425 article-title: The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies publication-title: Exp. Mol. Med. – volume: 114 year: 2014 ident: bb0095 article-title: Pathological unfoldomics of uncontrolled chaos: Intrinsically disordered proteins and human diseases publication-title: Chem. Rev. – volume: 72 year: 1993 ident: bb0360 article-title: A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes publication-title: Cell – volume: 122 year: 2022 ident: bb0105 article-title: Conformational dynamics of intrinsically disordered proteins regulate biomolecular condensate chemistry publication-title: Chem. Rev. – volume: 85 year: 1988 ident: bb0195 article-title: Differential loss of striatal projection neurons in Huntington disease publication-title: Proc. Natl. Acad. Sci. USA – volume: 12 year: 2020 ident: bb0370 article-title: Untangling the conformational polymorphism of disordered proteins associated with neurodegeneration at the single-molecule level publication-title: Front. Mol. Neurosci. – volume: 24 year: 2023 ident: bb0135 article-title: A guide to membraneless organelles and their various roles in gene regulation publication-title: Nat. Rev. Mol. Cell Biol. – volume: 24 year: 2018 ident: bb0410 article-title: Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent publication-title: Nat. Med. – year: 2016 ident: bb0450 article-title: Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins publication-title: J. Neurochem. – volume: 37 year: 2018 ident: bb0275 article-title: Tau protein liquid–liquid phase separation can initiate tau aggregation publication-title: EMBO J. – volume: 20 year: 2024 ident: bb0065 article-title: Systematic discovery of protein interaction interfaces using AlphaFold and experimental validation publication-title: Mol. Syst. Biol. – volume: 19 year: 2023 ident: bb0215 article-title: Synaptic degeneration in Alzheimer disease publication-title: Nat. Rev. Neurol. – volume: 1862 year: 2016 ident: bb0300 article-title: Glycation alter the process of tau phosphorylation to change tau isoforms aggregation property publication-title: Biochim. Biophys. Acta Mol. basis Dis. – volume: 30 year: 2023 ident: bb0415 article-title: Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery publication-title: Cell Stem Cell – volume: 7 year: 2014 ident: bb0420 article-title: Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons publication-title: Cell Rep. – volume: 12 year: 2019 ident: bb0455 article-title: Structural insights into TDP-43 and effects of post-translational modifications publication-title: Front. Mol. Neurosci. – volume: 291 year: 2024 ident: bb0070 article-title: Intrinsically disordered Pseudomonas chaperone FapA slows down the fibrillation of major biofilm-forming functional amyloid FapC publication-title: FEBS J. – volume: 52 year: 2024 ident: bb0100 article-title: DisProt in 2024: improving function annotation of intrinsically disordered proteins publication-title: Nucleic Acids Res. – volume: 13 year: 2009 ident: bb0225 article-title: Aβ aggregation and possible implications in Alzheimer’s disease pathogenesis publication-title: J. Cell. Mol. Med. – volume: 20 year: 2022 ident: bb0030 article-title: Intrinsically disordered proteins play diverse roles in cell signaling publication-title: Cell Commun. Signal. – volume: 121 year: 2022 ident: bb0125 article-title: Phase separation in amino acid mixtures is governed by composition publication-title: Biophys. J. – volume: 292 year: 2017 ident: bb0295 article-title: An acetylation–phosphorylation switch that regulates tau aggregation propensity and function publication-title: J. Biol. Chem. – volume: 76 year: 1986 ident: bb0250 article-title: Alzheimer’s disease: tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments publication-title: J. Neurol. Sci. – volume: 19 year: 2014 ident: bb0015 article-title: The triple power of D3: Protein intrinsic disorder in degenerative diseases publication-title: Front. Biosci. (Landmark) – volume: 23 year: 2022 ident: bb0090 article-title: Protein misfolding and aggregation in the brain: common pathogenetic pathways in neurodegenerative and mental disorders publication-title: Int. J. Mol. Sci. – volume: 2 year: 2011 ident: bb0285 article-title: The acetylation of tau inhibits its function and promotes pathological tau aggregation publication-title: Nat. Commun. – volume: 173 year: 2018 ident: bb0515 article-title: Stress granule assembly disrupts nucleocytoplasmic transport publication-title: Cell – volume: 1 year: 2020 ident: bb0175 publication-title: Alzheimers disease: a brief review – volume: 7 year: 2015 ident: bb0020 article-title: Intrinsically disordered proteins and their (disordered) proteomes in neurodegenerative disorders publication-title: Front. Aging Neurosci. – volume: 99 year: 2002 ident: bb0375 article-title: Huntington’s disease age-of-onset linked to polyglutamine aggregation nucleation publication-title: Proc. Natl. Acad. Sci. USA – volume: 14 year: 2022 ident: bb0010 article-title: Intrinsically disordered proteins and proteins with intrinsically disordered regions in neurodegenerative diseases publication-title: Biophys. Rev. – volume: 17 year: 2002 ident: bb0315 article-title: Pathophysiology of parkinsion’s disease: from clinical neurology to basic neuroscience and back publication-title: Mov. Disord. – volume: 24 year: 1999 ident: bb0190 article-title: From Charcot to SOD1: mechanisms of selective motor neuron death in ALS publication-title: Neuron – volume: 139 year: 2017 ident: bb0380 article-title: Monomeric Huntingtin exon 1 has similar overall structural features for wild-type and pathological polyglutamine lengths publication-title: J. Am. Chem. Soc. – volume: 10 year: 2013 ident: bb0335 article-title: α-synuclein and mitochondria: partners in crime? publication-title: Neurotherapeutics – volume: 6 year: 2004 ident: bb0185 article-title: Biology of Parkinson’s disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder publication-title: Dialogues Clin. Neurosci. – year: 2016 ident: bb0390 article-title: The genetics of amyotrophic lateral sclerosis: current insights publication-title: Degener. Neurol. Neuromuscul. Dis. – volume: 291 year: 2016 ident: bb0205 article-title: Modulation of intrinsically disordered protein function by post-translational modifications publication-title: J. Biol. Chem. – volume: 20 year: 2019 ident: bb0540 article-title: Design of the phase 3, randomised, placebo-controlled trial of oral arimoclomol in amyotrophic lateral sclerosis ORARIALS-01 publication-title: Amyotroph. Lateral Scler. Frontotemporal Degener. – volume: 7 year: 2011 ident: bb0385 article-title: Clinical diagnosis and management of amyotrophic lateral sclerosis publication-title: Nat. Rev. Neurol. – volume: 368 year: 2013 ident: bb0525 article-title: Autophagy in human health and disease publication-title: N. Engl. J. Med. – volume: 16 year: 1996 ident: bb0165 article-title: Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer’s disease publication-title: J. Neurosci. – volume: 120 year: 2023 ident: bb0055 article-title: Systematic identification of conditionally folded intrinsically disordered regions by AlphaFold2 publication-title: Proc. Natl. Acad. Sci. USA – volume: 10 year: 2021 ident: bb0480 article-title: HspB8 prevents aberrant phase transitions of FUS by chaperoning its folded RNA binding domain publication-title: Elife – volume: 60 year: 2015 ident: bb0460 article-title: Formation and maturation of phase-separated liquid droplets by RNA-binding proteins publication-title: Mol. Cell – volume: 10 year: 2021 ident: bb0500 article-title: Mechanisms and therapeutic implications of gsk-3 in treating neurodegeneration publication-title: Cells – volume: 371 year: 2021 ident: bb0485 article-title: HSP70 chaperones RNA-free TDP-43 into anisotropic intranuclear liquid spherical shells publication-title: Science (1979) – volume: 887 year: 2020 ident: bb0265 article-title: Alzheimer’s disease: recent treatment strategies publication-title: Eur. J. Pharmacol. – volume: 435 year: 2023 ident: bb0330 article-title: Functional and pathological effects of α-synuclein on synaptic SNARE complexes publication-title: J. Mol. Biol. – volume: 18 year: 2024 ident: bb0080 article-title: Intrinsically disordered proteins studied by NMR spectroscopy publication-title: J. Magn. Reson. Open – volume: 71 year: 2018 ident: bb0465 article-title: Poly(ADP-ribose) prevents pathological phase separation of TDP-43 by promoting liquid demixing and stress granule localization publication-title: Mol. Cell – year: 2012 ident: bb0235 article-title: Structure and pathology of tau protein in Alzheimer disease publication-title: Int. J. Alzheimers Dis. – volume: 114 year: 2014 ident: bb0025 article-title: Introduction to intrinsically disordered proteins (IDPs) publication-title: Chem. Rev. – volume: 9 year: 2021 ident: bb0340 article-title: Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro publication-title: Acta Neuropathol. Commun. – volume: 5 year: 2011 ident: bb0365 article-title: The biological function of the Huntingtin protein and its relevance to Huntington’s disease pathology publication-title: Curr. Trends Neurol. – volume: 37 year: 2022 ident: bb0040 article-title: Intrinsically disordered proteins identified in the aggregate proteome serve as biomarkers of neurodegeneration publication-title: Metab. Brain Dis. – volume: 176 year: 2019 ident: bb0160 article-title: Considerations and challenges in studying liquid-liquid phase separation and biomolecular condensates publication-title: Cell – volume: 11 year: 2022 ident: bb0350 article-title: Alpha-synuclein aggregation pathway in Parkinson’s disease: current status and novel therapeutic approaches publication-title: Cells – volume: 21 year: 2005 ident: bb0545 article-title: IUPred: web server for the prediction of intrinsically unstructured regions of proteins based on estimated energy content publication-title: Bioinformatics – volume: 82 year: 2023 ident: bb0110 article-title: Role of aberrant phase separation in pathological protein aggregation publication-title: Curr. Opin. Struct. Biol. – volume: 49 year: 2020 ident: bb0130 article-title: Physical Principles Underlying the Complex Biology of Intracellular Phase Transitions publication-title: Annu. Rev. Biophys. – volume: 12 year: 2021 ident: bb0155 article-title: Sequestration within biomolecular condensates inhibits Aβ-42 amyloid formation publication-title: Chem. Sci. – volume: 14 year: 2019 ident: bb0345 article-title: Alpha-synuclein structure and Parkinson’s disease - lessons and emerging principles publication-title: Mol. Neurodegener. – volume: 11 year: 2022 ident: bb0140 article-title: Regulation of cellular ribonucleoprotein granules: from assembly to degradation via post-translational modification publication-title: Cells – volume: 469 year: 2015 ident: bb0535 article-title: KEAP1-NRF2 signalling and autophagy in protection against oxidative and reductive proteotoxicity publication-title: Biochem. J. – volume: 69 year: 1995 ident: bb0440 article-title: Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs publication-title: J. Virol. – volume: 8 year: 2012 ident: bb0170 article-title: Alzheimer’s disease: Pathogenesis and prevention publication-title: Alzheimers Dement. – volume: 250 year: 2023 ident: bb0075 article-title: Intrinsic disorder may drive the interaction of PROS1 and MERTK in uveal melanoma publication-title: Int. J. Biol. Macromol. – volume: 1867 year: 2019 ident: bb0045 article-title: Application of native mass spectrometry in studying intrinsically disordered proteins: a special focus on neurodegenerative diseases publication-title: Biochim. Biophys. Acta, Proteins Proteomics – volume: 19 year: 2023 ident: bb0255 article-title: Tau-targeting therapies for Alzheimer disease: current status and future directions publication-title: Nat. Rev. Neurol. – volume: 11 year: 2022 ident: bb0530 article-title: Autophagy: a key regulator of homeostasis and disease: an overview of molecular mechanisms and modulators publication-title: Cells – volume: 6 year: 2014 ident: bb0325 article-title: Involvement of dopamine loss in extrastriatal basal ganglia nuclei in the pathophysiology of Parkinson’s disease publication-title: Front. Aging Neurosci. – volume: 276 year: 2001 ident: bb0280 article-title: Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local β-structure publication-title: J. Biol. Chem. – volume: 314 year: 2006 ident: bb0395 article-title: Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis publication-title: Science (1979) – volume: 3 year: 2022 ident: bb0120 article-title: Post-translational modifications in liquid-liquid phase separation: a comprehensive review publication-title: Mol. Biomed. – volume: 13 year: 2023 ident: bb0060 article-title: Rational drug design targeting intrinsically disordered proteins publication-title: Wiley Interdiscip. Rev. Comput. Mol. Sci. – volume: 387 year: 2022 ident: bb0355 article-title: Trial of Prasinezumab in early-stage Parkinson’s disease publication-title: N. Engl. J. Med. – volume: 26 year: 2016 ident: bb0505 article-title: Principles and properties of stress granules publication-title: Trends Cell Biol. – volume: 33 year: 1994 ident: bb0230 article-title: Solution structure of residues 1–28 of the amyloid β-peptide publication-title: Biochemistry – volume: 16 year: 2023 ident: bb0475 article-title: Phase separation and pathologic transitions of RNP condensates in neurons: implications for amyotrophic lateral sclerosis, frontotemporal dementia and other neurodegenerative disorders publication-title: Front. Mol. Neurosci. – volume: 14 year: 2009 ident: bb0035 article-title: Intrinsic disorder in proteins associated with neurodegenerative diseases publication-title: Front. Biosci. – volume: 39 year: 2003 ident: bb0180 article-title: Parkinson’s disease: mechanisms and models publication-title: Neuron – volume: 1 year: 1987 ident: bb0245 article-title: Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (?) publication-title: Alzheimer Dis. Assoc. Disord. – volume: 2016 year: 2016 ident: bb0320 article-title: Pathophysiology of motor dysfunction in Parkinson’s disease as the rationale for drug treatment and rehabilitation publication-title: Parkinsons Dis. – volume: 127 year: 2023 ident: bb0085 article-title: Delineating structural propensities of the 4E-BP2 protein via integrative modeling and clustering publication-title: J. Phys. Chem. B – volume: 83 year: 1986 ident: bb0240 article-title: Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (τ) publication-title: Proc. Natl. Acad. Sci. USA – volume: 82 year: 2022 ident: bb0310 article-title: Condensed-phase signaling can expand kinase specificity and respond to macromolecular crowding publication-title: Mol. Cell – volume: 11 year: 2020 ident: bb0305 article-title: Liquid-liquid phase separation induces pathogenic tau conformations in vitro publication-title: Nat. Commun. – volume: 430 year: 2018 ident: bb0200 article-title: Intrinsically disordered proteins link alternative splicing and post-translational modifications to complex cell signaling and regulation publication-title: J. Mol. Biol. – volume: 15 year: 2008 ident: bb0260 article-title: Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease publication-title: Curr. Med. Chem. – volume: 8 year: 2012 ident: bb0520 article-title: Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation publication-title: Nat. Chem. Biol. – volume: 433 year: 2021 ident: bb0050 article-title: AlphaFold and implications for intrinsically disordered proteins publication-title: J. Mol. Biol. – volume: 44 year: 2017 ident: bb0495 article-title: Designer protein disaggregases to counter neurodegenerative disease publication-title: Curr. Opin. Genet. Dev. – volume: 8 year: 2017 ident: bb0270 article-title: Liquid-liquid phase separation of the microtubule-binding repeats of the Alzheimer-related protein tau publication-title: Nat. Commun. – volume: 1868 year: 2021 ident: bb0510 article-title: Molecular mechanisms of stress granule assembly and disassembly publication-title: Biochim. Biophys. Acta, Mol. Cell Res. – volume: 52 year: 2024 ident: bb0470 article-title: Stress granule formation helps to mitigate neurodegeneration publication-title: Nucleic Acids Res. – volume: 29 year: 2022 ident: bb0400 article-title: iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders publication-title: Cell Stem Cell – volume: 23 year: 2022 ident: bb0005 article-title: Intrinsically disordered proteins: an overview publication-title: Int. J. Mol. Sci. – volume: 15 year: 2024 ident: bb0430 article-title: Molecular mechanisms of phase separation and amyloidosis of ALS/FTD-linked FUS and TDP-43 publication-title: Aging Dis. – volume: 59 year: 2019 ident: bb0405 article-title: Study protocol for a phase I/IIa, double-blind, placebo-controlled trial of ropinirole for ALS publication-title: Clin. Neurol. – volume: 64 year: 2018 ident: bb0220 article-title: Amyloid accumulation and cognitive decline in clinically normal older individuals: implications for aging and early Alzheimer’s disease publication-title: J. Alzheimers Dis. – volume: 8 year: 2021 ident: bb0210 article-title: The biological pathways of Alzheimer disease: a review publication-title: AIMS Neurosci. – volume: 121 year: 2008 ident: bb0435 article-title: Structural determinants of the cellular localization and shuttling of TDP-43 publication-title: J. Cell Sci. – volume: 85 year: 1988 ident: 10.1016/j.bbagen.2025.130772_bb0195 article-title: Differential loss of striatal projection neurons in Huntington disease publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.85.15.5733 – volume: 29 year: 2022 ident: 10.1016/j.bbagen.2025.130772_bb0400 article-title: iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders publication-title: Cell Stem Cell doi: 10.1016/j.stem.2022.01.007 – volume: 10 year: 2021 ident: 10.1016/j.bbagen.2025.130772_bb0500 article-title: Mechanisms and therapeutic implications of gsk-3 in treating neurodegeneration publication-title: Cells doi: 10.3390/cells10020262 – volume: 250 year: 2023 ident: 10.1016/j.bbagen.2025.130772_bb0075 article-title: Intrinsic disorder may drive the interaction of PROS1 and MERTK in uveal melanoma publication-title: Int. J. Biol. Macromol. doi: 10.1016/j.ijbiomac.2023.126027 – volume: 49 year: 2020 ident: 10.1016/j.bbagen.2025.130772_bb0130 article-title: Physical Principles Underlying the Complex Biology of Intracellular Phase Transitions publication-title: Annu. Rev. Biophys. doi: 10.1146/annurev-biophys-121219-081629 – volume: 20 year: 2024 ident: 10.1016/j.bbagen.2025.130772_bb0065 article-title: Systematic discovery of protein interaction interfaces using AlphaFold and experimental validation publication-title: Mol. Syst. Biol. doi: 10.1038/s44320-023-00005-6 – volume: 8 year: 2017 ident: 10.1016/j.bbagen.2025.130772_bb0270 article-title: Liquid-liquid phase separation of the microtubule-binding repeats of the Alzheimer-related protein tau publication-title: Nat. Commun. doi: 10.1038/s41467-017-00480-0 – volume: 13 year: 2023 ident: 10.1016/j.bbagen.2025.130772_bb0060 article-title: Rational drug design targeting intrinsically disordered proteins publication-title: Wiley Interdiscip. Rev. Comput. Mol. Sci. doi: 10.1002/wcms.1685 – volume: 11 year: 2022 ident: 10.1016/j.bbagen.2025.130772_bb0530 article-title: Autophagy: a key regulator of homeostasis and disease: an overview of molecular mechanisms and modulators publication-title: Cells doi: 10.3390/cells11152262 – volume: 10 year: 2013 ident: 10.1016/j.bbagen.2025.130772_bb0335 article-title: α-synuclein and mitochondria: partners in crime? publication-title: Neurotherapeutics doi: 10.1007/s13311-013-0182-9 – volume: 12 year: 2019 ident: 10.1016/j.bbagen.2025.130772_bb0455 article-title: Structural insights into TDP-43 and effects of post-translational modifications publication-title: Front. Mol. Neurosci. doi: 10.3389/fnmol.2019.00301 – volume: 52 year: 2024 ident: 10.1016/j.bbagen.2025.130772_bb0100 article-title: DisProt in 2024: improving function annotation of intrinsically disordered proteins publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkad928 – volume: 52 year: 2024 ident: 10.1016/j.bbagen.2025.130772_bb0470 article-title: Stress granule formation helps to mitigate neurodegeneration publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkae655 – volume: 82 year: 2023 ident: 10.1016/j.bbagen.2025.130772_bb0110 article-title: Role of aberrant phase separation in pathological protein aggregation publication-title: Curr. Opin. Struct. Biol. doi: 10.1016/j.sbi.2023.102678 – volume: 121 year: 2022 ident: 10.1016/j.bbagen.2025.130772_bb0125 article-title: Phase separation in amino acid mixtures is governed by composition publication-title: Biophys. J. doi: 10.1016/j.bpj.2022.09.031 – volume: 11 year: 2020 ident: 10.1016/j.bbagen.2025.130772_bb0305 article-title: Liquid-liquid phase separation induces pathogenic tau conformations in vitro publication-title: Nat. Commun. doi: 10.1038/s41467-020-16580-3 – volume: 6 year: 2004 ident: 10.1016/j.bbagen.2025.130772_bb0185 article-title: Biology of Parkinson’s disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder publication-title: Dialogues Clin. Neurosci. doi: 10.31887/DCNS.2004.6.3/galexander – volume: 17 year: 2002 ident: 10.1016/j.bbagen.2025.130772_bb0315 article-title: Pathophysiology of parkinsion’s disease: from clinical neurology to basic neuroscience and back publication-title: Mov. Disord. doi: 10.1002/mds.10140 – volume: 20 year: 2022 ident: 10.1016/j.bbagen.2025.130772_bb0030 article-title: Intrinsically disordered proteins play diverse roles in cell signaling publication-title: Cell Commun. Signal. doi: 10.1186/s12964-022-00821-7 – volume: 1868 year: 2021 ident: 10.1016/j.bbagen.2025.130772_bb0510 article-title: Molecular mechanisms of stress granule assembly and disassembly publication-title: Biochim. Biophys. Acta, Mol. Cell Res. doi: 10.1016/j.bbamcr.2020.118876 – volume: 114 year: 2014 ident: 10.1016/j.bbagen.2025.130772_bb0025 article-title: Introduction to intrinsically disordered proteins (IDPs) publication-title: Chem. Rev. doi: 10.1021/cr500288y – volume: 176 year: 2019 ident: 10.1016/j.bbagen.2025.130772_bb0160 article-title: Considerations and challenges in studying liquid-liquid phase separation and biomolecular condensates publication-title: Cell doi: 10.1016/j.cell.2018.12.035 – volume: 19 year: 2023 ident: 10.1016/j.bbagen.2025.130772_bb0215 article-title: Synaptic degeneration in Alzheimer disease publication-title: Nat. Rev. Neurol. doi: 10.1038/s41582-022-00749-z – volume: 121 year: 2008 ident: 10.1016/j.bbagen.2025.130772_bb0435 article-title: Structural determinants of the cellular localization and shuttling of TDP-43 publication-title: J. Cell Sci. doi: 10.1242/jcs.038950 – volume: 292 year: 2017 ident: 10.1016/j.bbagen.2025.130772_bb0295 article-title: An acetylation–phosphorylation switch that regulates tau aggregation propensity and function publication-title: J. Biol. Chem. doi: 10.1074/jbc.M117.794602 – volume: 1 year: 2020 ident: 10.1016/j.bbagen.2025.130772_bb0175 publication-title: J. Exp. Neurol. – volume: 291 year: 2024 ident: 10.1016/j.bbagen.2025.130772_bb0070 article-title: Intrinsically disordered Pseudomonas chaperone FapA slows down the fibrillation of major biofilm-forming functional amyloid FapC publication-title: FEBS J. doi: 10.1111/febs.17084 – volume: 16 year: 2023 ident: 10.1016/j.bbagen.2025.130772_bb0475 article-title: Phase separation and pathologic transitions of RNP condensates in neurons: implications for amyotrophic lateral sclerosis, frontotemporal dementia and other neurodegenerative disorders publication-title: Front. Mol. Neurosci. doi: 10.3389/fnmol.2023.1242925 – year: 2012 ident: 10.1016/j.bbagen.2025.130772_bb0235 article-title: Structure and pathology of tau protein in Alzheimer disease publication-title: Int. J. Alzheimers Dis. doi: 10.1155/2012/731526 – volume: 37 year: 2022 ident: 10.1016/j.bbagen.2025.130772_bb0040 article-title: Intrinsically disordered proteins identified in the aggregate proteome serve as biomarkers of neurodegeneration publication-title: Metab. Brain Dis. doi: 10.1007/s11011-021-00791-8 – volume: 173 year: 2018 ident: 10.1016/j.bbagen.2025.130772_bb0515 article-title: Stress granule assembly disrupts nucleocytoplasmic transport publication-title: Cell doi: 10.1016/j.cell.2018.03.025 – volume: 8 year: 2012 ident: 10.1016/j.bbagen.2025.130772_bb0170 article-title: Alzheimer’s disease: Pathogenesis and prevention publication-title: Alzheimers Dement. doi: 10.1016/j.jalz.2012.01.011 – volume: 30 year: 2023 ident: 10.1016/j.bbagen.2025.130772_bb0415 article-title: Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery publication-title: Cell Stem Cell doi: 10.1016/j.stem.2023.04.017 – volume: 69 year: 1995 ident: 10.1016/j.bbagen.2025.130772_bb0440 article-title: Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs publication-title: J. Virol. doi: 10.1128/jvi.69.6.3584-3596.1995 – volume: 15 year: 2024 ident: 10.1016/j.bbagen.2025.130772_bb0430 article-title: Molecular mechanisms of phase separation and amyloidosis of ALS/FTD-linked FUS and TDP-43 publication-title: Aging Dis. doi: 10.14336/AD.2023.1118 – volume: 314 year: 2006 ident: 10.1016/j.bbagen.2025.130772_bb0395 article-title: Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis publication-title: Science (1979) – volume: 1862 year: 2016 ident: 10.1016/j.bbagen.2025.130772_bb0300 article-title: Glycation alter the process of tau phosphorylation to change tau isoforms aggregation property publication-title: Biochim. Biophys. Acta Mol. basis Dis. doi: 10.1016/j.bbadis.2015.12.002 – volume: 33 year: 1994 ident: 10.1016/j.bbagen.2025.130772_bb0230 article-title: Solution structure of residues 1–28 of the amyloid β-peptide publication-title: Biochemistry doi: 10.1021/bi00191a006 – volume: 5 year: 2011 ident: 10.1016/j.bbagen.2025.130772_bb0365 article-title: The biological function of the Huntingtin protein and its relevance to Huntington’s disease pathology publication-title: Curr. Trends Neurol. – volume: 71 year: 2018 ident: 10.1016/j.bbagen.2025.130772_bb0465 article-title: Poly(ADP-ribose) prevents pathological phase separation of TDP-43 by promoting liquid demixing and stress granule localization publication-title: Mol. Cell doi: 10.1016/j.molcel.2018.07.002 – volume: 64 year: 2018 ident: 10.1016/j.bbagen.2025.130772_bb0220 article-title: Amyloid accumulation and cognitive decline in clinically normal older individuals: implications for aging and early Alzheimer’s disease publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-179928 – volume: 11 year: 2022 ident: 10.1016/j.bbagen.2025.130772_bb0350 article-title: Alpha-synuclein aggregation pathway in Parkinson’s disease: current status and novel therapeutic approaches publication-title: Cells doi: 10.3390/cells11111732 – volume: 368 year: 2013 ident: 10.1016/j.bbagen.2025.130772_bb0525 article-title: Autophagy in human health and disease publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra1205406 – volume: 430 year: 2018 ident: 10.1016/j.bbagen.2025.130772_bb0200 article-title: Intrinsically disordered proteins link alternative splicing and post-translational modifications to complex cell signaling and regulation publication-title: J. Mol. Biol. doi: 10.1016/j.jmb.2018.03.028 – volume: 24 year: 2018 ident: 10.1016/j.bbagen.2025.130772_bb0410 article-title: Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent publication-title: Nat. Med. doi: 10.1038/s41591-018-0140-5 – volume: 291 year: 2016 ident: 10.1016/j.bbagen.2025.130772_bb0205 article-title: Modulation of intrinsically disordered protein function by post-translational modifications publication-title: J. Biol. Chem. doi: 10.1074/jbc.R115.695056 – volume: 76 year: 1986 ident: 10.1016/j.bbagen.2025.130772_bb0250 article-title: Alzheimer’s disease: tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments publication-title: J. Neurol. Sci. doi: 10.1016/0022-510X(86)90167-X – volume: 122 year: 2022 ident: 10.1016/j.bbagen.2025.130772_bb0105 article-title: Conformational dynamics of intrinsically disordered proteins regulate biomolecular condensate chemistry publication-title: Chem. Rev. doi: 10.1021/acs.chemrev.1c00774 – year: 2016 ident: 10.1016/j.bbagen.2025.130772_bb0390 article-title: The genetics of amyotrophic lateral sclerosis: current insights publication-title: Degener. Neurol. Neuromuscul. Dis. – volume: 13 year: 2009 ident: 10.1016/j.bbagen.2025.130772_bb0225 article-title: Aβ aggregation and possible implications in Alzheimer’s disease pathogenesis publication-title: J. Cell. Mol. Med. doi: 10.1111/j.1582-4934.2009.00609.x – volume: 18 year: 2024 ident: 10.1016/j.bbagen.2025.130772_bb0080 article-title: Intrinsically disordered proteins studied by NMR spectroscopy publication-title: J. Magn. Reson. Open – volume: 72 year: 1993 ident: 10.1016/j.bbagen.2025.130772_bb0360 article-title: A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes publication-title: Cell doi: 10.1016/0092-8674(93)90585-E – volume: 59 year: 2019 ident: 10.1016/j.bbagen.2025.130772_bb0405 article-title: Study protocol for a phase I/IIa, double-blind, placebo-controlled trial of ropinirole for ALS publication-title: Clin. Neurol. – volume: 83 year: 1986 ident: 10.1016/j.bbagen.2025.130772_bb0240 article-title: Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (τ) publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.83.11.4040 – volume: 52 year: 2020 ident: 10.1016/j.bbagen.2025.130772_bb0425 article-title: The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies publication-title: Exp. Mol. Med. doi: 10.1038/s12276-020-00513-7 – volume: 26 year: 2016 ident: 10.1016/j.bbagen.2025.130772_bb0505 article-title: Principles and properties of stress granules publication-title: Trends Cell Biol. doi: 10.1016/j.tcb.2016.05.004 – volume: 9 year: 2022 ident: 10.1016/j.bbagen.2025.130772_bb0115 article-title: Liquid-liquid phase separation of TDP-43 and FUS in physiology and pathology of neurodegenerative diseases publication-title: Front. Mol. Biosci. doi: 10.3389/fmolb.2022.826719 – volume: 8 year: 2021 ident: 10.1016/j.bbagen.2025.130772_bb0210 article-title: The biological pathways of Alzheimer disease: a review publication-title: AIMS Neurosci. doi: 10.3934/Neuroscience.2021005 – volume: 371 year: 2021 ident: 10.1016/j.bbagen.2025.130772_bb0485 article-title: HSP70 chaperones RNA-free TDP-43 into anisotropic intranuclear liquid spherical shells publication-title: Science (1979) – volume: 276 year: 2001 ident: 10.1016/j.bbagen.2025.130772_bb0280 article-title: Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local β-structure publication-title: J. Biol. Chem. doi: 10.1074/jbc.M105196200 – volume: 14 year: 2022 ident: 10.1016/j.bbagen.2025.130772_bb0010 article-title: Intrinsically disordered proteins and proteins with intrinsically disordered regions in neurodegenerative diseases publication-title: Biophys. Rev. doi: 10.1007/s12551-022-00968-0 – volume: 19 year: 2014 ident: 10.1016/j.bbagen.2025.130772_bb0015 article-title: The triple power of D3: Protein intrinsic disorder in degenerative diseases publication-title: Front. Biosci. (Landmark) – volume: 3 year: 2022 ident: 10.1016/j.bbagen.2025.130772_bb0120 article-title: Post-translational modifications in liquid-liquid phase separation: a comprehensive review publication-title: Mol. Biomed. doi: 10.1186/s43556-022-00075-2 – volume: 24 year: 2023 ident: 10.1016/j.bbagen.2025.130772_bb0135 article-title: A guide to membraneless organelles and their various roles in gene regulation publication-title: Nat. Rev. Mol. Cell Biol. doi: 10.1038/s41580-022-00558-8 – volume: 7 year: 2015 ident: 10.1016/j.bbagen.2025.130772_bb0020 article-title: Intrinsically disordered proteins and their (disordered) proteomes in neurodegenerative disorders publication-title: Front. Aging Neurosci. doi: 10.3389/fnagi.2015.00018 – volume: 6 year: 2014 ident: 10.1016/j.bbagen.2025.130772_bb0325 article-title: Involvement of dopamine loss in extrastriatal basal ganglia nuclei in the pathophysiology of Parkinson’s disease publication-title: Front. Aging Neurosci. doi: 10.3389/fnagi.2014.00087 – volume: 433 year: 2021 ident: 10.1016/j.bbagen.2025.130772_bb0050 article-title: AlphaFold and implications for intrinsically disordered proteins publication-title: J. Mol. Biol. doi: 10.1016/j.jmb.2021.167208 – volume: 82 year: 2022 ident: 10.1016/j.bbagen.2025.130772_bb0310 article-title: Condensed-phase signaling can expand kinase specificity and respond to macromolecular crowding publication-title: Mol. Cell doi: 10.1016/j.molcel.2022.08.016 – volume: 7 year: 2014 ident: 10.1016/j.bbagen.2025.130772_bb0420 article-title: Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons publication-title: Cell Rep. doi: 10.1016/j.celrep.2014.03.019 – volume: 4 year: 2022 ident: 10.1016/j.bbagen.2025.130772_bb0150 article-title: Protein conformation and biomolecular condensates publication-title: Curr. Res. Struct. Biol. – volume: 7 year: 2011 ident: 10.1016/j.bbagen.2025.130772_bb0385 article-title: Clinical diagnosis and management of amyotrophic lateral sclerosis publication-title: Nat. Rev. Neurol. doi: 10.1038/nrneurol.2011.153 – volume: 114 year: 2014 ident: 10.1016/j.bbagen.2025.130772_bb0095 article-title: Pathological unfoldomics of uncontrolled chaos: Intrinsically disordered proteins and human diseases publication-title: Chem. Rev. doi: 10.1021/cr400713r – volume: 11 year: 2022 ident: 10.1016/j.bbagen.2025.130772_bb0140 article-title: Regulation of cellular ribonucleoprotein granules: from assembly to degradation via post-translational modification publication-title: Cells doi: 10.3390/cells11132063 – volume: 13 year: 2012 ident: 10.1016/j.bbagen.2025.130772_bb0445 article-title: Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration publication-title: Nat. Rev. Neurosci. doi: 10.1038/nrn3121 – volume: 16 year: 2007 ident: 10.1016/j.bbagen.2025.130772_bb0490 article-title: Hsp104: a weapon to combat diverse neurodegenerative disorders publication-title: NeuroSignals – volume: 20 year: 2019 ident: 10.1016/j.bbagen.2025.130772_bb0540 article-title: Design of the phase 3, randomised, placebo-controlled trial of oral arimoclomol in amyotrophic lateral sclerosis ORARIALS-01 publication-title: Amyotroph. Lateral Scler. Frontotemporal Degener. – volume: 15 year: 2008 ident: 10.1016/j.bbagen.2025.130772_bb0260 article-title: Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease publication-title: Curr. Med. Chem. doi: 10.2174/092986708785909111 – volume: 139 year: 2017 ident: 10.1016/j.bbagen.2025.130772_bb0380 article-title: Monomeric Huntingtin exon 1 has similar overall structural features for wild-type and pathological polyglutamine lengths publication-title: J. Am. Chem. Soc. doi: 10.1021/jacs.7b06659 – volume: 120 year: 2023 ident: 10.1016/j.bbagen.2025.130772_bb0055 article-title: Systematic identification of conditionally folded intrinsically disordered regions by AlphaFold2 publication-title: Proc. Natl. Acad. Sci. USA – volume: 23 year: 2022 ident: 10.1016/j.bbagen.2025.130772_bb0005 article-title: Intrinsically disordered proteins: an overview publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms232214050 – volume: 12 year: 2021 ident: 10.1016/j.bbagen.2025.130772_bb0155 article-title: Sequestration within biomolecular condensates inhibits Aβ-42 amyloid formation publication-title: Chem. Sci. doi: 10.1039/D0SC04395H – volume: 37 year: 2018 ident: 10.1016/j.bbagen.2025.130772_bb0275 article-title: Tau protein liquid–liquid phase separation can initiate tau aggregation publication-title: EMBO J. doi: 10.15252/embj.201798049 – volume: 887 year: 2020 ident: 10.1016/j.bbagen.2025.130772_bb0265 article-title: Alzheimer’s disease: recent treatment strategies publication-title: Eur. J. Pharmacol. doi: 10.1016/j.ejphar.2020.173554 – year: 2016 ident: 10.1016/j.bbagen.2025.130772_bb0450 article-title: Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins publication-title: J. Neurochem. doi: 10.1111/jnc.13625 – volume: 9 year: 2021 ident: 10.1016/j.bbagen.2025.130772_bb0340 article-title: Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro publication-title: Acta Neuropathol. Commun. doi: 10.1186/s40478-021-01288-2 – volume: 127 year: 2023 ident: 10.1016/j.bbagen.2025.130772_bb0085 article-title: Delineating structural propensities of the 4E-BP2 protein via integrative modeling and clustering publication-title: J. Phys. Chem. B doi: 10.1021/acs.jpcb.3c04052 – volume: 469 year: 2015 ident: 10.1016/j.bbagen.2025.130772_bb0535 article-title: KEAP1-NRF2 signalling and autophagy in protection against oxidative and reductive proteotoxicity publication-title: Biochem. J. – volume: 12 year: 2020 ident: 10.1016/j.bbagen.2025.130772_bb0370 article-title: Untangling the conformational polymorphism of disordered proteins associated with neurodegeneration at the single-molecule level publication-title: Front. Mol. Neurosci. doi: 10.3389/fnmol.2019.00309 – volume: 16 year: 1996 ident: 10.1016/j.bbagen.2025.130772_bb0165 article-title: Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer’s disease publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.16-14-04491.1996 – volume: 99 year: 2002 ident: 10.1016/j.bbagen.2025.130772_bb0375 article-title: Huntington’s disease age-of-onset linked to polyglutamine aggregation nucleation publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.182276099 – volume: 387 year: 2022 ident: 10.1016/j.bbagen.2025.130772_bb0355 article-title: Trial of Prasinezumab in early-stage Parkinson’s disease publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2202867 – volume: 44 year: 2017 ident: 10.1016/j.bbagen.2025.130772_bb0495 article-title: Designer protein disaggregases to counter neurodegenerative disease publication-title: Curr. Opin. Genet. Dev. doi: 10.1016/j.gde.2017.01.008 – volume: 24 year: 1999 ident: 10.1016/j.bbagen.2025.130772_bb0190 article-title: From Charcot to SOD1: mechanisms of selective motor neuron death in ALS publication-title: Neuron doi: 10.1016/S0896-6273(00)81108-3 – volume: 2 year: 2011 ident: 10.1016/j.bbagen.2025.130772_bb0285 article-title: The acetylation of tau inhibits its function and promotes pathological tau aggregation publication-title: Nat. Commun. doi: 10.1038/ncomms1255 – volume: 88 year: 2004 ident: 10.1016/j.bbagen.2025.130772_bb0290 article-title: Pseudophosphorylation of tau protein alters its ability for self-aggregation publication-title: J. Neurochem. doi: 10.1046/j.1471-4159.2003.02287.x – volume: 19 year: 2023 ident: 10.1016/j.bbagen.2025.130772_bb0255 article-title: Tau-targeting therapies for Alzheimer disease: current status and future directions publication-title: Nat. Rev. Neurol. doi: 10.1038/s41582-023-00883-2 – volume: 23 year: 2022 ident: 10.1016/j.bbagen.2025.130772_bb0090 article-title: Protein misfolding and aggregation in the brain: common pathogenetic pathways in neurodegenerative and mental disorders publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms232214498 – volume: 1 year: 1987 ident: 10.1016/j.bbagen.2025.130772_bb0245 article-title: Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (?) publication-title: Alzheimer Dis. Assoc. Disord. doi: 10.1097/00002093-198701030-00021 – volume: 14 year: 2019 ident: 10.1016/j.bbagen.2025.130772_bb0345 article-title: Alpha-synuclein structure and Parkinson’s disease - lessons and emerging principles publication-title: Mol. Neurodegener. doi: 10.1186/s13024-019-0329-1 – volume: 21 year: 2005 ident: 10.1016/j.bbagen.2025.130772_bb0545 article-title: IUPred: web server for the prediction of intrinsically unstructured regions of proteins based on estimated energy content publication-title: Bioinformatics doi: 10.1093/bioinformatics/bti541 – volume: 14 year: 2009 ident: 10.1016/j.bbagen.2025.130772_bb0035 article-title: Intrinsic disorder in proteins associated with neurodegenerative diseases publication-title: Front. Biosci. doi: 10.2741/3594 – volume: 435 year: 2023 ident: 10.1016/j.bbagen.2025.130772_bb0330 article-title: Functional and pathological effects of α-synuclein on synaptic SNARE complexes publication-title: J. Mol. Biol. doi: 10.1016/j.jmb.2022.167714 – volume: 2016 year: 2016 ident: 10.1016/j.bbagen.2025.130772_bb0320 article-title: Pathophysiology of motor dysfunction in Parkinson’s disease as the rationale for drug treatment and rehabilitation publication-title: Parkinsons Dis. – volume: 19 year: 2021 ident: 10.1016/j.bbagen.2025.130772_bb0145 article-title: Insight into membraneless organelles and their associated proteins: drivers, clients and regulators publication-title: Comput. Struct. Biotechnol. J. doi: 10.1016/j.csbj.2021.06.042 – volume: 10 year: 2021 ident: 10.1016/j.bbagen.2025.130772_bb0480 article-title: HspB8 prevents aberrant phase transitions of FUS by chaperoning its folded RNA binding domain publication-title: Elife doi: 10.7554/eLife.69377 – volume: 60 year: 2015 ident: 10.1016/j.bbagen.2025.130772_bb0460 article-title: Formation and maturation of phase-separated liquid droplets by RNA-binding proteins publication-title: Mol. Cell doi: 10.1016/j.molcel.2015.08.018 – volume: 39 year: 2003 ident: 10.1016/j.bbagen.2025.130772_bb0180 article-title: Parkinson’s disease: mechanisms and models publication-title: Neuron doi: 10.1016/S0896-6273(03)00568-3 – volume: 8 year: 2012 ident: 10.1016/j.bbagen.2025.130772_bb0520 article-title: Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio.797 – volume: 1867 year: 2019 ident: 10.1016/j.bbagen.2025.130772_bb0045 article-title: Application of native mass spectrometry in studying intrinsically disordered proteins: a special focus on neurodegenerative diseases publication-title: Biochim. Biophys. Acta, Proteins Proteomics doi: 10.1016/j.bbapap.2019.07.013 |
| SSID | ssj0000595 |
| Score | 2.4835374 |
| SecondaryResourceType | review_article |
| Snippet | Neurodegenerative diseases such as Amyotrophic Lateral Sclerosis, Alzheimer's disease, Parkinson's disease, and Huntington's disease share a common... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 130772 |
| SubjectTerms | Aggregation alpha-Synuclein - metabolism Alzheimer disease amyotrophic lateral sclerosis Animals Autophagy Chaperone drugs Humans Intrinsically disordered proteins Intrinsically Disordered Proteins - metabolism Liquid-liquid phase separation Neurodegenerative diseases Neurodegenerative Diseases - metabolism Neurodegenerative Diseases - pathology Parkinson disease proteasome endopeptidase complex Proteasome Endopeptidase Complex - metabolism Proteostasis separation therapeutics toxicity |
| Title | The roles of intrinsically disordered proteins in neurodegeneration |
| URI | https://dx.doi.org/10.1016/j.bbagen.2025.130772 https://www.ncbi.nlm.nih.gov/pubmed/39954969 https://www.proquest.com/docview/3167357278 https://www.proquest.com/docview/3200263687 |
| Volume | 1869 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NS8NAEB1KRfQiWr_qR4ngNdZkk2xyLEWpil5U6G3Z7G6kUtKi8eDF3-7MblLxUAtekwksM7uzL8ybNwDnPJdRnEvjFylnfsRV7stC4s8KXd95mhkZU7_z_UMyeo5ux_G4BcOmF4ZolXXudzndZuv6Sb_2Zn8-mfQfqaiHcILqclYFhjrYI060vouvH5oHwofYVRIin6yb9jnL8cpzPLSkghrGNBaZ83DZ9bQMftpr6Hobtmr86A3cEnegZcoOrLuJkp8d2Bg2A9x2YYhbwCP24Ls3K7xJWb1NShuT6aena9FNoz2r1IBv0MKz6pbavFgtagrZHjxfXz0NR349M8FX6IwK84UJFWIig0jhsgiTLFUZ04wFgZZSJ9QmqwOlOB4OTLkk2JYWSrMCUVOaJYVm-9AuZ6U5BA8DF0gmZXKps0grmSMSwHgzxSVmhVR2gTWuEqoWFKe5FlPRMMdehXOwIAcL5-Au-Iuv5k5QY4U9b6Igfm0MgTl_xZdnTdAEep4KIbI0s493Qd3_LEbklv5hQ-yVBN3Du3DgIr5YL7UDR1mSHf17bcewicgrcxSgE2hXbx_mFNFNlffs9u3B2uDmbvTwDZni-Es |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB7WXUQv4tv1WcFrWdu0TXuURanu46LC3kKapLIiXdHuYf-9M2m74kEXvDYTCN8kk69k5huAK57JIMykcfOYMzfgKnNlLvFnha7vLE6MDKneeTSO0ufgYRJOWtBvamEorbKO_VVMt9G6_tKr0ey9T6e9R3rUQzpB73JWBWYNOqROFbShc3M_SMffATm0zVfI3qUJTQWdTfPKMjy3JITqh9QZmXP_txvqNwZqb6K7bdiqKaRzU61yB1qm2IX1qqnkYhc2-k0Ptz3o4y5wKIHw05nlzrQoP6aFdcvbwtG17qbRjhVrwBG0cKzApTYvVo6avLYPz3e3T_3UrdsmuArxKDFkGF8hLTJIFq5zP0pilTDNmOdpKXVElbLaU4rj-cCoS5ptca40y5E4xUmUa3YA7WJWmCNw0HeeZFJG1zoJtJIZkgF0OVNcYmCIZRdYA5VQtaY4tbZ4E03y2KuoABYEsKgA7oK7nPVeaWqssOeNF8SPvSEw7K-Yedk4TSDy9BYiCzObfwoSAGAhkrf4DxtKYIkQHt6Fw8rjy_VSRXCQRMnxv9d2ARvp02gohvfjwQls0kiVEXQK7fJjbs6Q7JTZeb2ZvwAeNPr5 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+roles+of+intrinsically+disordered+proteins+in+neurodegeneration&rft.jtitle=Biochimica+et+biophysica+acta.+General+subjects&rft.au=Utami%2C+Kagistia+Hana&rft.au=Morimoto%2C+Satoru&rft.au=Mitsukura%2C+Yasue&rft.au=Okano%2C+Hideyuki&rft.date=2025-04-01&rft.eissn=1872-8006&rft.volume=1869&rft.issue=4&rft.spage=130772&rft_id=info:doi/10.1016%2Fj.bbagen.2025.130772&rft_id=info%3Apmid%2F39954969&rft.externalDocID=39954969 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-4165&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-4165&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-4165&client=summon |